Full name
PHARMACY GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,3 | -0 | 0 | 1790,4 |
Gross profit (loss) | 0,4 | -0 | -0 | -682,4 |
EBITDA | 0,5 | 0 | 0 | -98,6 |
Short time liabilities | 0,8 | 0,7 | 0,7 | -7,2 |
Other operating costs | 0 | 0 | 0,1 | 2333 |
Equity capital | 0,9 | 0,9 | 0,9 | -1,7 |
Operating profit (EBIT) | 0,4 | -0 | -0 | -854,2 |
Assets | 1,7 | 1,7 | 1,6 | -5,4 |
Net profit (loss) | 0,3 | -0 | -0 | 11,9 |
Cash | 0,5 | 0,3 | 0,5 | 62,7 |
Liabilities and provisions for liabilities | 0,8 | 0,9 | 0,8 | -9,2 |
Net income from sale | 9,1 | 10 | 9,8 | -2,1 |
Working assets | 1,7 | 1,7 | 1,6 | -5,3 |
Other income costs | 0,1 | 0 | 0 | 382,3 |
Depreciation | 0,1 | 0 | 0 | -31,1 |
% | % | % | p.p. | |
Profitability of capital | 33,7 | -2 | -1,8 | 0,2 |
Equity capital to total assets | 51,2 | 50,2 | 52,2 | 2 |
Gross profit margin | 3,9 | -0 | -0,1 | -0,1 |
EBITDA Margin | 5 | 0,2 | 0 | -0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 30 | 27 | 25 | -2 |
Current financial liquidity indicator | 2.279569625854492 | 2.3601415157318115 | 2.4081926345825195 | 0 |
Net dept to EBITDA | -1.0009855031967163 | -19.007919311523438 | -2219.423828125 | -2200,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane